BlueLight Therapeutics

company

About

BlueLight Therapeutics uses a proprietary structure-based platform to discover small molecules against difficult-to-drug targets.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.10M
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2000
Number Of Employee
11 - 50
Operating Status
Active

BlueLight Therapeutics uses a proprietary structure-based platform to discover small molecules against difficult-to-drug targets.

BlueLight Therapeutics leverages a proprietary, structure-driven platform to develop novel therapeutic molecules against challenging, high-value drug targets. The company has a passionate and experienced team with unique expertise on developing structural assays across a broad range of target classes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.20M
BlueLight Therapeutics has raised a total of $1.20M in funding over 2 rounds. Their latest funding was raised on Sep 20, 2013 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 20, 2013 Grant $100K 1 National Science Foundation Detail
Mar 18, 2013 Grant $1.10M 1 National Science Foundation Detail

Investments

Number of Investments
Number of Lead Investments
2
0
BlueLight Therapeutics has made 2 investments. Their most recent investment was on Oct 13, 2011, when DuckDuckGo raised $3M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 13, 2011 DuckDuckGo
Series Unknown $3M Internet
Jun 30, 2010 YipitData
Series A $1.30M Analytics

Investors

Number of Lead Investors
Number of Investors
2
1
BlueLight Therapeutics is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant